Ropivacaine Hydrochloride Injection, Solution
Product Images NDC 83854-014

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ropivacaine Hydrochloride (NDC 83854-014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Anthea Pharma Private Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

"image Description" (150mg 30ml Carton Label)

Ropivacaine Hydrochloride Injection, USP 0.5% (150 mg/30 mL or 5 mg/mL) carton for injection solution by Anthea Pharma Private Limited. The label states use for infiltration, nerve block, and epidural administration only, excluding intravenous use. It contains five 30 mL single-dose vials. The packaging includes dosage and storage details and barcode information.*

FDA Label Image

"image Description" (150mg 30ml Container Label)

Ropivacaine Hydrochloride Injection, USP 0.5% (150 mg/30 mL, 5 mg/mL) in a 30 mL single-dose vial. The label specifies use for infiltration, nerve block, and epidural administration only, not for intravenous use. Manufactured by Anthea Pharma Private Limited, Hyderabad, India. Includes storage instructions, contents per mL, and lot/expiration placeholders.*

FDA Label Image

"image Description" (200mg 20ml Carton Label)

Ropivacaine Hydrochloride Injection, USP 1% (10 mg/mL), 200 mg per 20 mL single-dose vial carton by Anthea Pharma. The label shows the product is for epidural administration only and not for intravenous use. It contains 25 vials of 20 mL each and includes storage and usage instructions.*

FDA Label Image

"image Description" (200mg 20ml Container Label)

Ropivacaine Hydrochloride Injection USP 1% (10 mg/mL) in a 20 mL single-dose vial by Anthea Pharma Private Limited. The label indicates the product is for epidural administration only, not for intravenous use, with sterile solution containing no preservatives. Storage and manufacturing details are also displayed.*

FDA Label Image

"image Description" (40mg 20ml Carton Label)

Packaging label for Ropivacaine Hydrochloride Injection USP 0.2% (40 mg/20 mL; 2 mg/mL) by Anthea Pharma Private Limited. The label is for single-dose vials, twenty-five 20 mL vials per package. It states routes of administration as infiltration, nerve block, and epidural, with no intravenous use. Storage instructions and NDC 83854-013-25 are also shown.*

FDA Label Image

"image Description" (40mg 20ml Container Label)

Ropivacaine Hydrochloride Injection USP 0.2% (2 mg/mL) single-dose vial, 20 mL (40 mg total) by Anthea Pharma Private Limited. Label specifies use for infiltration, nerve block, and epidural administration only, not for intravenous use. Contains no preservatives, with instructions to discard unused portion and store at 20°C to 25°C.*

FDA Label Image

"image Description" (Structure 01)

Chemical structure of Ropivacaine Hydrochloride, shown with its molecular formula including HCl and H2O components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.